HCC
PBH icon

Hirtle Callaghan & Co’s Prestige Consumer Healthcare PBH Stock Holding History

Hirtle Callaghan & Co’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,529
Closed -$502K – 128
2022
Q2 		$502K Sell
8,529
-1,365
-14% -$75.3K 0.03% 80
2022
Q1 		$524K Buy
+9,894
New +$571K 0.03% 85

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Hirtle Callaghan & Co's PBH Position: Q3 2022 in Review

Hirtle Callaghan & Co sold out of Prestige Consumer Healthcare (PBH) in Q3 2022, closing a stake of 8,529 shares — an estimated $502K sold.

Hirtle Callaghan & Co first reported a position in PBH in Q1 2022 and held it in 2 quarters. The position peaked at $524K in Q1 2022. 279 funds tracked by Wall St. Rank hold PBH as of Q3 2022.

  • Hirtle Callaghan & Co reported no remaining Prestige Consumer Healthcare position as of Q3 2022 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 8,529 Prestige Consumer Healthcare shares in Q3 2022, an estimated $502K.
  • Hirtle Callaghan & Co first reported a position in Prestige Consumer Healthcare in Q1 2022 and held it in 2 quarters.
  • Hirtle Callaghan & Co's Prestige Consumer Healthcare position peaked at $524K in Q1 2022.
  • 279 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2022.

Based on Hirtle Callaghan & Co's 13F filing for Q3 2022, filed 14 Nov 2022.